Estimands in Oncology Trials

In this article, PPD’s cross-functional Estimands working group explores how the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use’s (ICH) E9 addendum impacts oncology clinical trials.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.